Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02357147
Title Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM). (ARTEMIS)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Morphotek
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | DEU | AUS

No variant requirements are available.